Drugs@FDA document

TRADJENTA Letter · NDA 201280 SUPPL-25

Drugs@FDA document · BOEHRINGER INGELHEIM · Apr 18, 2022

Key facts

Drug name TRADJENTA
Document type Letter
Application NDA201280
Submission SUPPL-25
Company BOEHRINGER INGELHEIM
Document date Apr 18, 2022

At a glance

  • Labeling-Package Insert Document categories
  • 10–99 Documents for this application
  • 1–9 USP chapters cited in this application's documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents